QbD Group
    点播网络研讨会

    ATMP Supply Chain: Navigating the Challenges and Exploring the Vein-to-Vein Strategy

    In this webinar we dive into the fascinating world of the ATMP (Advanced Therapy Medicinal Products) supply chain. Discover how to overcome the main challenges faced by industry leaders and gain fascinating insights into the innovative vein-to-vein strategy. Through real-life examples and visuals, we will explore the roadmap to navigate the ATMP supply chain and unlock its full potential.

    随时观看
    60 分钟
    Pharma & Biotech
    Chinese

    ial.

    Watch webinar on demand

    What you'll learn

    • Key challenges in the ATMP supply chain and strategies to overcome them
    • Insights into the innovative "vein to vein" supply chain approach
    • Practical, real-life examples and visuals to understand ATMP logistics
    • A roadmap to unlock the full potential of ATMPs
    • How to lead the way in next-generation healthcare solutions

    向最优秀的人学习

    演讲者

    Join us as our expert speaker shares valuable insights and practical knowledge drawn from extensive industry experience.

    Register here

    Keep watching

    More webinars

    From Strategy to First-in-Human: A Practical Roadmap for Biotech Development 点播网络研讨会

    From Strategy to First-in-Human: A Practical Roadmap for Biotech Development

    Regulatory Affairs2026年3月18日

    Early-stage biotech teams often struggle to translate scientific innovation into first-in-human readiness. This webinar provides practical guidance to help teams build a clear, scalable development pathway that aligns regulatory strategy, CMC, quality, and clinical planning. Reducing risk, avoiding delays, and staying inspection-ready without overbuilding internal structures.

    立即观看
    Pharmacovigilance and Risk Management in Innovative Therapies 点播网络研讨会

    Pharmacovigilance and Risk Management in Innovative Therapies

    Pharmacovigilance2025年5月15日

    The webinar discusses the evolving pharmacovigilance and risk management environment of innovative therapies, emphasizing safety challenges in cell, CAR T, and RNA-based treatments, as well as gaps in regulation and surveillance strategies. Participants will gain insight into the origin and impact of safety concerns in these therapies, alongside ongoing developments in RNA-based treatments.

    立即观看

    订阅生命科学领域的最新动态

    专家观点直达您的收件箱——选择您的兴趣。

    绝无垃圾邮件。随时取消订阅。

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.